how many americans take glp 1 drugs Ozempic Statistics: GLP-1 Weight Loss Medication Data Chart: Most Americans Prefer Exercise

263 GregersenSJeppesenPBHolstJJHermansenK

Our drug-target MR study provides suggestive evidence that increased GLP-1R gene expression and the associated reduction in HbA1c levels mediated by GLP-1RAs could potentially lower the risk of SA

The muted experience of GLP-1 appetite suppression is a good thing taken too far

Importantly for the availability of coverage across the workforce, the share of firms with 5,000 or more workers covering these medications for weight loss increased significantly over the last year (from 28% in 2024 to 43% in 2025)

Orforglipron has shown statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in a successful Phase III trial